Testicular Cancer Treatment in India 2026: Orchiectomy, Chemotherapy & Cure Rates for International Patients
Testicular cancer is the most common cancer in men aged 15 to 35, and it carries some of the best cure rates of any malignancy when diagnosed and treated appropriately. In high-income countries, 95%+ cure rates for early-stage disease are routine. In many African countries, late presentation, diagnostic delays, and limited access to platinum-based chemotherapy mean outcomes lag far behind. India's urology-oncology centres deliver world-class testicular cancer care at a fraction of Western costs.
TL;DR: Testicular cancer cure rates in India are 95–99% for Stage I and II seminoma. Orchiectomy costs USD 2,500–4,500. BEP chemotherapy (3–4 cycles) costs USD 4,000–8,000. RPLND costs USD 6,000–10,000. Full staging and treatment starts from USD 8,000 for early-stage disease.
Testicular Cancer Types and Staging
Germ Cell Tumours
Over 95% of testicular cancers are germ cell tumours (GCTs), arising from the sperm-producing cells:
Seminoma: Pure seminoma is the most common GCT, typically presenting in men aged 30–40. Seminomas are highly radiosensitive and chemosensitive, explaining their excellent outcomes.
Non-seminomatous germ cell tumours (NSGCTs): Include embryonal carcinoma, yolk sac tumour, choriocarcinoma, and teratoma. These tend to present in younger men (20–30 years) and behave more aggressively. Mixed GCTs contain both seminomatous and non-seminomatous elements.
Staging
| Stage | Definition | Treatment |
|---|---|---|
| Stage I | Confined to testis | Orchiectomy + surveillance OR adjuvant chemo/RT |
| Stage II | Retroperitoneal lymph nodes | BEP chemotherapy ± RPLND |
| Stage IIC/III | Bulky nodes or distant metastasis | BEP chemotherapy (3–4 cycles) |
Tumour Markers
AFP (alpha-fetoprotein), beta-HCG, and LDH are essential diagnostic and monitoring markers. Elevated AFP with pure seminoma histology suggests mixed GCT. Markers should be measured at diagnosis, after orchiectomy (with expected half-life decline), and throughout treatment to monitor response.
Orchiectomy: The First Step
Radical inguinal orchiectomy — removal of the affected testicle through a groin incision — is the cornerstone of treatment for all testicular GCTs. The inguinal approach (not transscrotal) is critical to avoid disrupting lymphatic drainage patterns that would complicate staging and RPLND.
In India: The procedure takes 45 to 60 minutes under general or spinal anaesthesia. Hospital stay is 1 to 2 nights. The excised testicle is sent for complete histopathological analysis to determine tumour type, vascular invasion, and rete testis involvement — all critical for subsequent management.
Testicular prosthesis: A silicone prosthesis can be inserted at the time of orchiectomy or as a later procedure. Most Indian urology centres offer this. Discuss this option with your surgeon before the procedure.
Sperm banking: Before any treatment that may affect fertility (chemotherapy, RPLND), sperm banking should be considered. Indian hospitals offer cryopreservation facilities. For bilateral orchiectomy or high-risk chemotherapy regimens, banking before treatment is strongly advisable.
BEP Chemotherapy
BEP (Bleomycin, Etoposide, Cisplatin) is the standard first-line chemotherapy regimen for metastatic or high-risk testicular GCTs. Each cycle is 5 days of treatment given every 3 weeks.
Standard regimens:
- 3 cycles BEP: Stage IIA/B seminoma, Stage II NSGCT, selected Stage I high-risk NSGCT
- 4 cycles BEP: Stage IIC/III, all advanced GCT
Toxicities managed at Indian centres:
- Cisplatin nephrotoxicity: aggressive IV hydration protocols
- Bleomycin pulmonary toxicity: regular DLCO monitoring, bleomycin omitted if concerning
- Etoposide myelosuppression: G-CSF support for high-risk cycles
- Cisplatin ototoxicity: audiometry baseline and monitoring
Costs in India: USD 1,200–2,000 per BEP cycle including hospitalisation, drugs, and monitoring. Three cycles total: USD 3,600–6,000. Four cycles: USD 4,800–8,000.
RPLND: Retroperitoneal Lymph Node Dissection
RPLND is the surgical removal of retroperitoneal lymph nodes — the primary drainage basin for testicular GCTs. Indications include:
- Clinical Stage IIA/B NSGCT: primary RPLND as alternative to chemotherapy
- Residual retroperitoneal masses after chemotherapy
- Teratoma in residual mass (teratoma is chemoresistant)
- Relapsed GCT
Nerve-Sparing RPLND
Bilateral RPLND can cause retrograde ejaculation (failure of ejaculation) by damaging sympathetic nerves. Indian centres with high RPLND volume perform nerve-sparing RPLND, preserving ejaculatory function in 85–90% of cases.
Laparoscopic and robotic RPLND are available at select Indian centres for selected cases — reduced blood loss, faster recovery, but requires high surgical volume to maintain oncological adequacy.
Costs in India: USD 6,000–10,000 for primary RPLND. Post-chemotherapy RPLND for large residual masses is more complex: USD 8,000–14,000.
Surveillance After Treatment
After completing treatment, testicular cancer survivors require structured surveillance to detect relapse early:
Year 1–2: CT chest/abdomen/pelvis every 3 months, tumour markers every 3 months
Year 3–5: CT and markers every 6 months
Year 5+: Annual review
Relapses — even in Stage III disease — are usually still curable with salvage chemotherapy (TIP or VeIP regimens) or high-dose chemotherapy with autologous stem cell rescue, available at Indian oncology centres.
Why India for Testicular Cancer Treatment?
For African patients, the combination of factors making India compelling is:
- Cure rates matching Western outcomes — 95%+ for Stage I/II seminoma
- BEP chemotherapy cost — USD 4,000–8,000 total versus USD 40,000–80,000 in USA
- Cisplatin availability — not always available or properly dosed in many African centres
- Multidisciplinary team approach — urology, medical oncology, radiation oncology all collaborating
- Sperm banking — available at major centres
For broader context on cancer treatment costs, see our cancer treatment cost comparison guide. For patients requiring other oncological care, read our chemotherapy cost in India guide.
Do not delay if you or someone you know has a testicular mass. The difference between Stage I and Stage III at diagnosis can be the difference between one minor surgery and months of chemotherapy. Contact Arodya for a same-week oncology consultation appointment.
